Pacira BioSciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Pacira BioSciences, Inc. (NASDAQ: PCRX) has announced its participation in the 41st Annual J.P. Morgan Healthcare Conference, scheduled for January 9, 2023, at 3:00 PM PT (6:00 PM EST). Interested parties can access a live audio stream of the event on the company’s investor website, with a replay available for two weeks post-event. Pacira aims to provide non-opioid alternatives for pain management, emphasizing its commitment to reducing opioid dependency. The company has three commercial products: EXPAREL, ZILRETTA, and iovera.

TAMPA, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 41^st Annual J.P. Morgan Healthcare Conference at 3:00 PM PT (6:00PM EST) on Monday, January 9, 2023. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira         

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain, and spasticity. Pacira has three commercial-stage non-opioid treatments: EXPAREL^® (bupivacaine liposome injectable suspension), a long-acting, local analgesia currently approved for postsurgical pain management; ZILRETTA^® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº^®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

FAQ

When will Pacira BioSciences present at the J.P. Morgan Healthcare Conference in 2023?

Pacira BioSciences will present at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 3:00 PM PT (6:00 PM EST).

How can I listen to the Pacira BioSciences presentation at the conference?

The presentation can be accessed via a live audio stream on the company’s investor website.

What products does Pacira BioSciences offer?

Pacira BioSciences offers three commercial-stage products: EXPAREL, ZILRETTA, and iovera.

What is the focus of Pacira BioSciences regarding pain management?

Pacira BioSciences focuses on providing non-opioid treatment options to manage pain and reduce opioid dependency.

What is the significance of the 41st Annual J.P. Morgan Healthcare Conference for Pacira?

The conference provides Pacira with a platform to present its innovative pain management solutions and company mission to investors.